Introduction
Cnongenital pulmonary lymphangiectasis (CPL) is a rare cause of respiratory distress in neonates and infants. A late presentation past the neonatal period with a better outcome and higher rate of survival had been described.' Further support for this observation is presented.
We report 3 cases in whom congenital pulmonary lymphangiectasis symptoms appeared during infancy after an uneventful neonatal period. The patients had been stable with only self-limited episodes of mild deterioration over a follow-up period of 1 to 2 years. Cytometric analysis of the broncho-alveolar lavage fluid in 2 cases revealed high eosinophil levels.
Patients
Three infants presented at the age of 3 to 4 months with respiratory distress expressed as tachypnea, chest retractions, perioral cyanosis, and crepitations that were heard over both lungs. They were delivered at term after an uneventful pregnancy, and had a normal perinatal course. The clinical characteristics and laboratory workup are presented in Table 1 .
No abnormalities were disclosed on laboratory evaluation (biochemistry tests, immunoglobulines, alpha-I antitrypsin, and anti-neutrophil cytoplasmic antibodies (ANCA): cANCA/pANCA), and thorough infectious workups were negative. Gastroesophageal reflux was excluded with 24-hour esophageal pH monitoring and barium videofluoroscopy, the tuberculuin test was negative, and sweat chloride level was normal.
Two infants underwent fiberoptic bronchoscopy with broncho-alveolar lavage fluid (BALF) analysis. BALF cytology showed neutrophilia (20% to 35%) and increased number of eosinophils, 6% and 11%, in cases 1 and 2, respectively. BALF cultures and direct antigen detection were negative.
Pulmonary function tests ("baby box") revealed moderateto-severe small airway obstruction, and echocardiography was normal in all cases. Chest radiography showed mild hyperinflation with perihilar reticulonodular and interstitial infiltrates in all of them.
High-resolution computed tomography (HR-CT) was performed in 2 phases: lungs inflated to total lung capacity (TLC) using an endotracheal tube or a laryngeal mask with expiratory hold at TLC, and at end exhalation. The HR-CTs in all three cases showed patchy areas of air trapping, mainly in the lower lobes without vascular abnormalities, findings compatible with non-homogenous small airway obstruction, and ground glass appearance in the subpleural areas.
A therapeutic trial with inhaled budesonide and albuterol and followed by intravenous methylprednisolone 2 mg/kg/day failed to elicit any clinical improvement. Three days of "pulse therapy" (methylprednisolone 15 mg/kg/day) in patient 1 yielded no change. Therapeutic trial with diuretics failed in all patients.
Open lung biopsies were performed after a follow-up period of 1 to 6 months. The histologic findings in all 3 patients revealed dilated lymphatic vessels in the subpleural spaces and interlobular septa with a flat endothelial lining compatible with congenital pulmonary lymphangiectasis (Figure 1 ).
The clinical manifestations during a follow-up period of 8 to 18 months was very similar in the 3 cases. At present (1 to 2 years follow up), the patients are relatively stable with mild respiratory distress including tachypnea and chest retractions, as well as mild crepitations over the lung bases. They breathe room air while awake with pulse oximetry satura-tions of 92% to 96%. During sleep, oxygen saturation decreases to 86% to 92% requiring the addition of 0.5 to 1 L/min of oxygen by nasal cannula resulting in saturation > 94%. Patient 1 showed improved saturation shortly after crying and when in an upright position. All 3 patients have failed to thrive, but they achieved all psychomotor milestones for their age.
Discussion
Congenital pulmonary lymphangiectasis, first described in 1856, is a rare anomaly, characterized by abnormal dilated lymphatic vessels resulting in obstruction and leakage of lymphatic fluid.1 According to Noonan's classification, pulmonary lymphangiectasis can be divided into 3 groups: a) primary developmental anomaly of the pulmonary lymphatic, b) generalized lymphatic abnormality, and c) acquired pulmonary lymphangiec-tasia secondary to pulmonary venous obstruction or cardiac abnormalities.2 Diagnosis is based upon open lung biopsy and histological examinations.3 Our reported cases had an uneventful neonatal period and their disease did not present until 3 to 4 months of age. Nevertheless, their polycytemia on presentation indicates that they had been hypoxemic for some clinically asymptomatic period before presentation. There were no other congenital anomalies.
The primary disorder that is restricted to the lungs is fatal in the neonatal period.3 The relatively late presentation in our patients and the survival without significant deterioration over the first 1 to 2 years of life adds further support to the observation that an improved prognosis is associated with a later presentation.4
The non-homogenous images of the HR-CTs imply that the lung pathology in these cases may not involve all areas of the lungs but that it is rather restricted to parts of them.4,5 To the best of our knowledge this is the first description of cy-tologic analysis of BALF in CPL and the first reporting of elevated eosinophils. Whether eosinophilia accompanies CPL and should be included in the differential diagnosis of disorders of pulmonary infiltrates with eosinophilia awaits further investigations. 
